TickerFacts.

Acro Biomedical Co., Ltd. (ACBM): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$18.1K
As of 2020-12-31
$37.6K2015-09-30: $27.3K2016-09-30: $2.5K2017-09-30: $36.8K2018-09-30: $1.1K2018-12-31: $37.6K2019-09-30: $1.5K2019-12-31: $9112020-12-31: $18.1K$18.1K
2015-09-30 Cash & Equivalents (USD) 2020-12-31
Period endedCash & EquivalentsChange YoYSource filing
2020-12-31$18.1Kn/m2021-04-02, Balance as of period end
2019-12-31$911n/a2021-04-02, Balance as of period end
2019-09-30$1.5Kn/a2020-01-07, Balance as of period end
2018-12-31$37.6Kn/a2021-04-02, Balance as of period end
2018-09-30$1.1K-96.9%2020-01-07, Balance as of period end
2017-09-30$36.8Kn/m2018-12-28, Balance as of period end
2016-09-30$2.5K-90.7%2018-01-16, Balance as of period end
2015-09-30$27.3Kn/a2016-12-16, Balance as of period end